Global Crisis and Germany‘s Contribution to the Global Response. Fourth Civil Society Appraisal on Germany’s Contribution to the Realization of the International HIV/AIDS Commitments since 2001 -- read now ...
Patents and Alternatives
Recent Additions
Links
- www.unitaid.eu
- The official website of UNITAID (in English and French)
- www.med4all.org
- An international conference at Charité Universitätsmedizin Berlin discussed new concepts how to improve drug supply for developing countries, for instance with the project "equitable licenses". Publicly funded research plays a key role in the development of new medicines, laying the ground for medical products.
- Here your will find congress documentation and the presentations for download.
Films and Flash
- Four flash movies films by Médecins Sans Frontières
- "Push for the Pool" Campaign Video on Youtube
- Student stop aids campaign to raise awareness of the Patent pool initiative which would allow developing countries access to life saving drugs at prices they can afford.
- To Join the "Push for the Pool" and find out more about the patent pool please visit www.stopaidscampaign.org.uk
- December 2008
Archive Documents
- Indian Generics and Aids: A Fact Finding Mission in the “Pharmacy of the Poor”
- A leaflet by "Action against Aids Germany", July 2009
- See the videos of the trip to India on our movie pages
- In March 2009, ten delegates of Action against AIDS Germany including three international guests visited India to meet four generic companies (Cipla, Hetero, Aurobindo and Matrix) that produce first and second line generic antiretroviral drugs (ARVs) and members of civil society groups (Lawyers Collective, Alternative Law Forum, MILANA, LOCOST, All India Drug Action Network).
- Open Letter to WHO Member States on outstanding components of Plan of Action on Public Health, Innovation and Intellectual Property
- Essential Action, Health Action International, Health Gap, Knowledge Ecology International, Medecins Sans Frontieres, Oxfam International, Third World Network
- 18. May 2009
- Advanced Market Commitments - Current Realities and Alternate Approaches
- The purpose of an advanced market commitment (AMC) was to motivate research and development (R&D) based pharmaceutical companies to conduct research into the so called ‘neglected diseases’ that primarily afflict low-income countries. In addition, AMCs were to speed-up access to new vaccines that are often delayed by 10-15 years because of their high prices when new on the market.
- Quelle: HAI Europe, medico international
- March 2009
- The Medicines Patent Pool Initiative by UNITAID
- UNITAID is working to establish an international system boost the availability of new and more patient-friendly medicines for people in developing countries. Through a collective management structure for medicines patents, known as a patent pool, UNITAID seeks to improve access to patents and foster the development and production of life-saving, more affordable, and more suitable medicines. Although such a ‘pool’ structure has shown its worth in many areas – agriculture and information technology, for example - the UNITAID initiative will lead to the first patentpool for medicines.
- also see the Medicines Patent Pool: Questions & Answers
- by UNITAID
- March 2009
- UNITAID Statement on GSK Patent Pool for Neglected Diseases
- UNITAID welcomes GlaxoSmithKline’s (GSK’s) announcement last week that it will tackle neglected diseases in least developed countries and place its patents for the necessary medicines into a pool...